- Home
- ALAB vs BAX Comparison
ALAB vs BAX Comparison
Compare ALAB & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAB
- BAX
- Stock Information
- Founded
- ALAB 2017
- BAX 1931
- Country
- ALAB United States
- BAX United States
- Employees
- ALAB N/A
- BAX N/A
- Industry
- ALAB
- BAX Medical/Dental Instruments
- Sector
- ALAB
- BAX Health Care
- Exchange
- ALAB NYSE
- BAX Nasdaq
- Market Cap
- ALAB 15.0B
- BAX 15.7B
- IPO Year
- ALAB 2024
- BAX N/A
- Fundamental
- Price
- ALAB $95.79
- BAX $28.67
- Analyst Decision
- ALAB Strong Buy
- BAX Buy
- Analyst Count
- ALAB 15
- BAX 8
- Target Price
- ALAB $97.50
- BAX $36.50
- AVG Volume (30 Days)
- ALAB 4.9M
- BAX 4.0M
- Earning Date
- ALAB 08-05-2025
- BAX 08-05-2025
- Dividend Yield
- ALAB N/A
- BAX 2.37%
- EPS Growth
- ALAB N/A
- BAX N/A
- EPS
- ALAB 0.26
- BAX N/A
- Revenue
- ALAB $490,474,000.00
- BAX $10,771,000,000.00
- Revenue This Year
- ALAB $80.73
- BAX $8.05
- Revenue Next Year
- ALAB $28.94
- BAX $4.19
- P/E Ratio
- ALAB $374.78
- BAX N/A
- Revenue Growth
- ALAB 200.19
- BAX 15.36
- 52 Week Low
- ALAB $36.22
- BAX $26.25
- 52 Week High
- ALAB $147.39
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- ALAB N/A
- BAX 37.02
- Support Level
- ALAB N/A
- BAX $29.57
- Resistance Level
- ALAB N/A
- BAX $31.15
- Average True Range (ATR)
- ALAB 0.00
- BAX 0.90
- MACD
- ALAB 0.00
- BAX -0.16
- Stochastic Oscillator
- ALAB 0.00
- BAX 5.07
About ALAB ASTERA LABS INC
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.